Epidemiology of hidradenitis suppurativa and its comorbid conditions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39626996.
- Also identified by DOI 10.1016/j.jaad.2024.09.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hidradenitis suppurativa (HS) is a chronic, inflammatory condition predominantly affecting younger adults and disproportionately affecting women and Black Americans. Estimated prevalences vary significantly according to study methodology; however, true prevalence may range from approximately 0.1% to 1%. Hidradenitis suppurativa is associated with a number of comorbid conditions which also contribute to poor health outcomes and negative impact on quality of life. Recent advancements in our understanding of disease burden in hidradenitis suppurativa have allowed us to identify subgroups of the population afflicted with the disease and to implement strategies which facilitate comprehensive care.
Medical subject headings
- Comorbidity
- Hidradenitis Suppurativa